Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Oropharyngeal Neoplasms 1Mouth Neoplasms 1Lymphedema 1Lung Neoplasms 1Lung Diseases 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Carcinoma 1

Interventions

Cisplatin 5nimotuzumab 2X-Rays 2Radiotherapy 2Magnetic Resonance Spectroscopy 2trifluridine tipiracil drug combination 1sargramostim 1palladium-bacteriopheophorbide 1padeliporfin 1imgatuzumab 1galactomannan 1futuximab 1fluoromisonidazole 1capmatinib 1cabozantinib 1Tomography, Optical Coherence 1Standard of Care 1Specimen Handling 1Ramucirumab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Practice Guidelines as Topic 1Platinum 1Nivolumab 1N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 1Mitomycin 1LMB-100 1Ipilimumab 1Interviews as Topic 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma × Drug Delivery Systems × Clear all
NCT05512767 2023-01-06

A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation

Mayo Clinic

Phase NA Withdrawn
Head & Neck

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡